Recent insider trading activity from Cote Elissa S., including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2026 | Vistagen Therapeutics, Inc. | $VTGN | Cote Elissa S. | Chief Corp Development Officer | A | Incentive Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 42,234,405 | 9999.99% | 0.18% |
| June 23, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Cote Elissa S. | Chief Corp Development Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 29,157,733 | 9999.99% | 0.51% |